Skip to content

A Comparative Study With Parenteral Oxycodone, Morphine and Dexamethasone in Postoperative Pain in Paediatric Patients

A Comparative Study With Pre-Emptive Parenteral Oxycodone, Morphine and Dexamethasone in the Treatment of Postoperative Pain in Paediatric Patients 4 to 12 Years of Age

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00733083
Acronym
DOM
Enrollment
100
Registered
2008-08-12
Start date
2008-09-30
Completion date
2010-12-31
Last updated
2008-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Tonsillectomy Pain

Keywords

tonsillectomy, paediatric, pain, child, opiates, pre-emptive, oxycodone, morphine, dexamethasone

Brief summary

The aim of this randomized, double-blind study is to compare parenteral pre-emptive oxycodone, morphine and dexamethasone with placebo in the treatment of postoperative pain in paediatric patients 4 to 12 years of age. The investigators hope to find out whether there are any differences in postoperative pain and/or adverse effects among these groups.

Detailed description

After the induction of anaesthesia and before intubation the child receives one of the research drugs in a double-blind fashion: 0.1 mg/kg of oxycodone , 0.1 mg/kg of morphine, 0.5 mg/kg dexamethasone (max 24 mg), or placebo. All the research drugs are diluted into a dose of 10 ml with NaCl 0.9%, the placebo being solely the dilute. The patients are followed minimum 4h postoperatively: first in the recovery room, and after the patient is stable enough the study is continued in the day-patient unit. Level of pain and adverse effects are registered all on same predetermined intervals being 15 min during the first postoperative hour, followed by interval of 30 min until the discharge. The safety measurements noted include pulse, respiratory rate, non-invasive blood pressure and peripheral oxygen saturation are recorded on the same intervals The registering of pain, adverse effects and given medication continues at home for 48 hours post operatively with a questionnaire filled by the parents.

Interventions

DRUG0,1 mg/kg of oxycodone

solution for injection, 0,1 mg/kg, one injection in the beginning of anesthesia

DRUGMorphine 0,1 mg/kg

solution for injection, 0,1 mg/kg, one injection in the beginning of anesthesia

DRUGDexamethasone 0,5 mg/kg

solution for injection, 0,5 mg/kg, one injection in the beginning of anesthesia

solution for injection one injection in the beginning of anesthesia

Sponsors

University of Turku
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* 4 to 12 years of age * Scheduled to tonsillectomy * ASA class I or II * Written informed consent is obtained from the parents and the child (when appropriate).

Exclusion criteria

* Allergy to morphine, oxycodone or dexamethasone

Design outcomes

Primary

MeasureTime frame
The difference of needed rescue pain medication post operativelypredetermined intervals being 15 min during the first postoperative hour, followed by interval of 30 min for 4 first postop hours. At home pain and adverse effects are registered by parent at 24 hours and 48 hours.

Secondary

MeasureTime frame
differences in adverse effectsIn hospital 4 hours with first hour in 15 min intervals, then 30 min. At home 24+48h

Countries

Finland

Contacts

Primary ContactMari S Aallos-Ravenna, MD
mari.aallos-ravenna@tyks.fi+35823130655
Backup ContactTuula Manner, MD
tuula.manner@tyks.fi+35823130962

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026